0000899243-20-025739.txt : 20200918
0000899243-20-025739.hdr.sgml : 20200918
20200918171238
ACCESSION NUMBER: 0000899243-20-025739
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200916
FILED AS OF DATE: 20200918
DATE AS OF CHANGE: 20200918
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Subramanian Romesh
CENTRAL INDEX KEY: 0001824655
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39509
FILM NUMBER: 201184669
MAIL ADDRESS:
STREET 1: C/O DYNE THERAPEUTICS, INC.
STREET 2: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dyne Therapeutics, Inc.
CENTRAL INDEX KEY: 0001818794
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 364883909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781) 786-8230
MAIL ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-09-16
0
0001818794
Dyne Therapeutics, Inc.
DYN
0001824655
Subramanian Romesh
C/O DYNE THERAPEUTICS, INC.
830 WINTER STREET
WALTHAM
MA
02451
0
1
1
0
Chief Scientific Officer
Common Stock
2020-09-17
4
A
0
41309
0.00
A
566249
D
Stock Option (right to buy)
19.00
2020-09-16
4
A
0
128185
0.00
A
2030-09-15
Common Stock
128185
128185
D
Consists of shares of Common Stock issuable under 41,309 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal annual installments over four years with the first installment vesting on September 17, 2021.
This option was granted on September 16, 2020. The shares underlying the option are scheduled to vest over four years in equal monthly installments through September 16, 2024.
/s/ Richard Scalzo, Attorney-in-Fact
2020-09-18